Best Agrolife Q3 FY26 results on Feb 6, call Feb 9

What the company has announced

Best Agrolife Ltd has scheduled a board meeting on February 6, 2026 to consider and approve its unaudited financial results for the quarter ended December 31, 2025. The company disclosed the development through a stock exchange communication dated January 28, 2026. The disclosure cites compliance with SEBI (LODR) Regulations, 2015, including Regulation 29. Alongside the board meeting, the company has also indicated that an earnings call is set for February 9, 2026. The call is expected to discuss the unaudited financial and operational performance for Q3 FY26.

Board meeting on February 6: agenda and compliance

The February 6 board meeting is positioned as the formal approval step for Q3 FY26 unaudited results. The quarter under review ended on December 31, 2025. Such meetings are a standard requirement before results are published to exchanges. Best Agrolife’s intimation to BSE specifically states the intent to “consider and approve” the unaudited financial results. The timing also aligns with the market’s usual earnings season cadence. The company’s stated “upcoming earnings date” is February 6, 2026.

Earnings call scheduled for February 9, 2026

Best Agrolife has scheduled its Q3 FY26 earnings call for February 9, 2026. The stated purpose is to discuss unaudited financial and operational results for the quarter ended December 31, 2025. This creates a short, structured timeline: board approval first, followed by management interaction. For investors, this sequence typically helps separate the statutory approval of numbers from the broader operational explanation. The company has not shared further details in the provided text about call timing, dial-in details, or presentation materials. What is clear is that the discussion is tied to Q3 FY26 performance.

Trading window closure until February 8

In continuation of an earlier communication dated December 24, 2025, Best Agrolife confirmed that the trading window for its securities remains closed until Sunday, February 8, 2026. The closure coincides with the result finalisation and board approval process. Trading window closures are commonly used to manage compliance around unpublished price sensitive information. Here, the closure extends beyond the February 6 board meeting date and ends shortly before the February 9 earnings call. The company has framed the closure as part of standard regulatory compliance.

Bonus shares and stock split: proposals and record date

Best Agrolife also outlined corporate actions involving a stock split and bonus issue. An EGM was scheduled for December 29, 2025 to approve a sub-division of equity shares from a face value of ₹10 to ₹1 per share. The same EGM agenda included a 1:2 bonus issue, meaning 1 bonus share for every 2 shares held. The company later fixed Friday, January 16, 2026 as the record date for determining eligible shareholders for the sub-division and bonus issue. These steps are separate from quarterly earnings, but they influence the capital structure and share count.

Bonus allotment completed on January 19, 2026

Following approvals from BSE and NSE, Best Agrolife completed the allotment of bonus shares in the 1:2 ratio on January 19, 2026. The company allotted 11,82,23,700 fully paid-up equity shares of ₹1 each to eligible shareholders. As a result, the paid-up capital increased from ₹23.64 crore to ₹35.47 crore. The allotment was approved by the Board of Directors in its meeting held on January 19, 2026. The record date referenced for this process was January 16, 2026.

Key dates and actions at a glance

FY25 financial snapshot from the annual report

In its annual report for the year ended March 31, 2025, Best Agrolife disclosed both standalone and consolidated performance. On a standalone basis, total revenue was ₹1,143.65 crore compared with ₹1,798.35 crore in the previous financial year. Standalone profit after tax (PAT) was ₹44.47 crore compared with ₹13.46 crore in the previous financial year. On a consolidated basis, total revenue was ₹1,814.31 crore compared with ₹1,873.31 crore in the previous financial year. Consolidated PAT stood at ₹69.89 crore compared with ₹106.27 crore in the previous financial year. The report also states EBITDA for the year stood at ₹200 crore and PAT was ₹70 crore.

Dividend, warrants, and auditor appointment updates

For FY25, the Board recommended a final dividend of ₹3 per share (30%) on equity shares of face value ₹10 each, the same rate as the previous year. If declared at the AGM scheduled for Tuesday, September 30, 2025, the total dividend outflow would be ₹7.09 crore, unchanged from the previous year. The record date for the dividend was set as September 23, 2025, with payment on or after September 30, 2025. Separately, the Board and members at meetings held on September 4, 2024 and September 30, 2024 approved issuance and allotment of 31,25,000 convertible warrants at a price of ₹640 each. The stated use of proceeds included growth funding, working capital, debt repayment, and general corporate purposes.

Why these disclosures matter for shareholders

The February 6 board meeting and February 9 earnings call provide the market a clear window into Best Agrolife’s Q3 FY26 performance for the quarter ended December 31, 2025. The trading window closure through February 8 indicates that the company is in a sensitive period for financial information handling. Meanwhile, the bonus issue, stock split, and the large bonus allotment completed on January 19, 2026 are material corporate actions that reshape the company’s equity base and the number of shares outstanding. The FY25 annual report figures provide context on recent revenue and profit trends that investors may compare against the upcoming Q3 FY26 results. The next formal milestone in this sequence is the board-approved Q3 FY26 unaudited results, followed by management commentary on the earnings call.